Product Description
DAFLON 500 mg is an oral phlebotropic drug indicated in the treatment of venous disease, i.e, chronic venous insufficiency (CVI) and haemorrhoidal disease (HD). Origin and composition of DAFLON 500 mg DAFLON 500 mg, micronized, purified flavonoid fraction (MPFF), is a semisynthetic phlebotropic drug whose active ingredients are micronized diosmin (90%) and hesperidin (10%). Hesperidin is extracted from a species of Rutaceae aurantieae of the citrus genus, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material.